Mork Capital Management LLC Invests $1 Million in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Mork Capital Management LLC purchased a new stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 52,800 shares of the medical instruments supplier's stock, valued at approximately $1,002,000.

A number of other large investors also recently modified their holdings of the business. Moore Capital Management LP acquired a new position in DENTSPLY SIRONA during the fourth quarter worth about $2,248,000. Lazard Asset Management LLC grew its holdings in DENTSPLY SIRONA by 23.0% during the fourth quarter. Lazard Asset Management LLC now owns 8,044,228 shares of the medical instruments supplier's stock worth $152,678,000 after acquiring an additional 1,505,928 shares during the period. Invenomic Capital Management LP grew its holdings in DENTSPLY SIRONA by 201.0% during the fourth quarter. Invenomic Capital Management LP now owns 2,639,161 shares of the medical instruments supplier's stock worth $50,091,000 after acquiring an additional 1,762,428 shares during the period. Jacobs Levy Equity Management Inc. acquired a new position in DENTSPLY SIRONA during the fourth quarter worth about $5,793,000. Finally, Gotham Asset Management LLC grew its holdings in DENTSPLY SIRONA by 8.5% during the fourth quarter. Gotham Asset Management LLC now owns 770,809 shares of the medical instruments supplier's stock worth $14,630,000 after acquiring an additional 60,111 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Gregory T. Lucier purchased 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. This represents a 22.66% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.50% of the stock is owned by corporate insiders.

DENTSPLY SIRONA Stock Up 1.2%

NASDAQ:XRAY traded up $0.20 on Friday, hitting $16.70. 2,469,701 shares of the company's stock traded hands, compared to its average volume of 2,965,827. The company has a market cap of $3.33 billion, a PE ratio of -8.07, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 1 year low of $12.16 and a 1 year high of $28.44. The firm has a 50-day moving average price of $14.41 and a 200-day moving average price of $17.38.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.14. The business had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The firm's revenue was down 7.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.42 EPS. Equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current fiscal year.

DENTSPLY SIRONA Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 3.83%. DENTSPLY SIRONA's dividend payout ratio is -14.10%.

Analyst Ratings Changes

XRAY has been the topic of a number of research analyst reports. Mizuho lowered their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Morgan Stanley cut DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target on the stock. in a research note on Tuesday, April 15th. Piper Sandler dropped their price target on DENTSPLY SIRONA from $20.00 to $16.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 30th. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research note on Friday, February 28th. Finally, StockNews.com raised DENTSPLY SIRONA from a "hold" rating to a "buy" rating in a research note on Friday, May 9th. Eleven analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, DENTSPLY SIRONA presently has a consensus rating of "Hold" and an average target price of $20.36.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.